Opportunities and Threats in the Indian Pharmaceutical Industry
Posted on: Tuesday, 26 June 2007, 09:15 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c60759) has announced the addition of "The Indian Pharmaceutical Industry" to their offering.
The report describes various aspects of the Indian Pharmaceutical Industry and focuses the various opportunities and threats that have emerged as a result of change in the regulatory environment.
The report stresses on the following issues:
The current state of the Indian pharmaceutical industry and past growth trends
The change in the regulatory environment of the industry with the advent of product patent regime
New opportunities and threats that have emerged for the Indian pharmaceutical companies as a result of these regulatory changes
The value road for Indian pharma companies that describes the strategic options available for achieving long term sustainable growth
Explanation of various business and R&D strategies pursued by Indian pharma companies
Analysis of the generics opportunity in the regulated markets
Strategic mapping of top Indian pharmaceutical companies showing their relative position with respect to the value road
A brief overview of ten major pharmaceutical companies in India and various strategies followed by them
Areas covered:
The Global Pharmaceutical Market: An Overview
The Indian Pharmaceutical Industry: An Overview
Indian Pharmaceutical Industry: Structure & classification
Indian Pharmaceutical Market: A Profile
Indian Pharmaceutical Industry: Regulatory Framework
Indian Pharmaceutical Industry Value Road
Business & R&D Strategies
Strategic Mapping of Indian Pharmaceutical Companies
Company Overview
Companies mentioned:
Ranbaxy Ltd.
Cipla Ltd.
Dr. Reddy's Laboratories Ltd.
Nicholas Piramal India Ltd.
Biocon Ltd.
Cadila Healthcare Ltd.
Matrix Laboratories Ltd.
Lupin Ltd.
Glenmark Pharmaceuticals Ltd.
Sun Pharamceutical Industries Ltd.
For more information visit http://www.researchandmarkets.com/reports/c60759
Source: Business Wire
Related Articles
- BVR Systems Announces Receipt of Notice From Milestones Upgrading & Industries Company Ltd.
- Research and Markets: This Essential Report Comprehensively Examines the Indian Pharmaceutical Industry
- Research and Markets: Tokyo Gas Co., Ltd. Analysis Across The Oil and Gas Value Chain Provides Historical Production and Capacity Data on This Exciting Company
- Study the Primary Objectives of the Indian Pharmaceutical Industry
- The Report 'Indian Food Processing Industry' Provides an Insight on Indian Food Habits, Constraints and Emerging Opportunities in the Industry
- Inflazyme Pharmaceuticals Ltd., To Appear On MN1.Com Today
- Inflazyme Pharmaceuticals Ltd., To Appear On MN1.Com
- It is Estimated That the UK Pharmaceutical Market Grew By 10.5% in 2004, to a Value of GBP 12.32bn
- R&D Collaborative Opportunities Abound in the Indian Pharmaceutical Industry
User Comments (0)

RSS Feeds